Search Results - "Gunby, Rosalind H."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias by Gambacorti-Passerini, Carlo B, Gunby, Rosalind H, Piazza, Rocco, Galietta, Annamaria, Rostagno, Roberta, Scapozza, Leonardo

    Published in The lancet oncology (01-02-2003)
    “…Imatinib (STI571 or CGP57148B) is an innovative treatment for tumours with a constitutively activated form of c-ABL, c-KIT, or PDGFR. Such tumours include…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    A Mechanistic Design Principle for Protein Tyrosine Kinase Sensors:  Application to a Validated Cancer Target by Wakata, Aya, Cahill, Sean M, Blumenstein, Michael, Gunby, Rosalind H, Jockusch, Steffen, Marti, Angel A, Cimbro, Barbara, Gambacorti-Passerini, Carlo, Donella-Deana, Arianna, Pinna, Lorenzo A, Turro, Nicholas J, Lawrence, David S

    Published in Organic letters (17-01-2008)
    “…A new mechanistic principle for reporting the phosphorylation of tyrosine is described, which should prove applicable to even the most fastidious of protein…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers by Brunet, C L, Gunby, R H, Benson, R S, Hickman, J A, Watson, A J, Brady, G

    Published in Cell death and differentiation (01-01-1998)
    “…Kinetic analysis of dexamethasone-induced apoptosis in the human lymphoblastoid cell line CCRF CEM C7A has revealed a point when cells, morphologically…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy by Gunby, Rosalind H, Sala, Elisa, Tartari, Carmen J, Puttini, Miriam, Gambacorti-Passerini, Carlo, Mologni, Luca

    Published in Anti-cancer agents in medicinal chemistry (01-11-2007)
    “…Deregulated activation of protein tyrosine kinases (PTKs) is a frequent event underlying malignant transformation in many types of cancer. The formation of…”
    Get more information
    Journal Article
  12. 12

    Generation and Verification of a Three-Dimensional Model of the ALK Kinase Domain: ALK - a “Supermutant” of Abl by Gunby, Rosalind H., Sottocornola, Roberta, Gasser, Marc, Scapozza, Leonardo, Gambacorti-Passerini, Carlo

    Published in Blood (16-11-2004)
    “…Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase that plays a key role in oncogenesis in a subset of non-Hodgkin's lymphomas, through the…”
    Get full text
    Journal Article
  13. 13

    CD40-Triggered Protein Tyrosine Phosphorylation on Vav and on Phosphatidylinositol 3-Kinase Correlates with Survival of the Ramos–Burkitt Lymphoma B Cell Line by Padmore, Lauren, An, Sungkwan, Gunby, Rosalind H., Kelly, Ken, Radda, George K., Knox, Kirstine A.

    Published in Cellular immunology (01-05-1997)
    “…Signals transduced through CD40 rescue cells of the Ramos–Burkitt lymphoma (Ramos-BL) B cell line from surface immunoglobulin M (sIgM)-triggered growth arrest…”
    Get full text
    Journal Article